Emerging opportunities include advancements in mRNA and viral vector technologies for rapid development, improved distribution through digital tracking, and public-private partnerships enhancing ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

HealthSecretary Robert F. Kennedy Jr. has defunded research in messenger RNA vaccines, which could jeopardize efforts to ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, an expert at Michigan State University ...

What makes this doubly frustrating is that Kennedy and his back-to-the-past approach to public health would be better off ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...

The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial.